Sanofi inks deal to help Sau­di Ara­bia man­u­fac­ture vac­cines lo­cal­ly

In June, Sau­di Ara­bia’s Pub­lic In­vest­ment Fund es­tab­lished Lif­era, a con­tract de­vel­op­er and man­u­fac­tur­er in the phar­ma­ceu­ti­cal field, and now the com­pa­ny has se­cured a ma­jor client.

On Wednes­day, Lif­era and the Sau­di-based vac­cine man­u­fac­tur­er Arab Phar­ma­ceu­ti­cal Com­pa­ny, or Ara­bio, signed a mem­o­ran­dum of un­der­stand­ing with Sanofi to boost the lo­cal vac­cine pro­duc­tion with­in Sau­di Ara­bia.

Un­der the terms of the agree­ment, all three com­pa­nies will search for op­por­tu­ni­ties to col­lab­o­rate to form a lo­cal­iza­tion strat­e­gy for de­vel­op­ing and pro­duc­ing vac­cines.

Unlock this article instantly by becoming a free subscriber.

You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER